Biochips Market

Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.
Biochips Market contains market size and forecasts of Biochips in global, including the following market information:
Global Biochips Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biochips Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Biochips companies in 2021 (%)
The global Biochips market was valued at 9777.5 million in 2021 and is projected to reach US$ 17540 million by 2028, at a CAGR of 8.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DNA Chip Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biochips include Abbott, Agilent Technologies, Illumina, PerkinElmer, Thermo Fisher Scientific, BioChain, Bio-Rad Laboratories, Cepheid and EMD Millipore, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biochips manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biochips Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biochips Market Segment Percentages, by Type, 2021 (%)
DNA Chip
Lab-on-a-Chip
Protein Chip
Others
Global Biochips Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biochips Market Segment Percentages, by Application, 2021 (%)
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users
Global Biochips Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biochips Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biochips revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biochips revenues share in global market, 2021 (%)
Key companies Biochips sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Biochips sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Agilent Technologies
Illumina
PerkinElmer
Thermo Fisher Scientific
BioChain
Bio-Rad Laboratories
Cepheid
EMD Millipore
Fluidigm
SuperBioChips Laboratories
US Biomax
Roche Diagnostics